Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FBIOP | ||||
| Company | Fortress Biotech Inc 9.375% Series A Cumulativ | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 20.15 | ||||
| High | 20.15 | ||||
| Low | 20.10 | ||||
| Latest | 20.14 | ||||
| Change | +0.13 | ||||
| % Change | +0.64% | ||||
| Volume | 3,539 | ||||
| 20-Day Average Volume | 36,367 | ||||
| Previous Close | 20.01 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 20.24 | ||||
| 20-Day Raw Stochastic | 62.38% | ||||
| 20-Day Relative Strength | 66.67 | ||||
| Weighted Alpha | +162.24 | ||||
| Today's Opinion | 88% Buy | ||||
| Previous Opinion | 88% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.55% since 06/16/26 | ||||
| Low | 19.75 on 06/23/26 | ||||
| High | 20.81 on 06/17/26 | ||||
| 1-Month | |||||
| %Chg | +20.59% since 05/22/26 | ||||
| Low | 17.01 on 05/26/26 | ||||
| High | 21.43 on 06/15/26 | ||||
| 3-Month | |||||
| %Chg | +51.87% since 03/24/26 | ||||
| Low | 12.75 on 03/26/26 | ||||
| High | 21.43 on 06/15/26 | ||||
| 6-Month | |||||
| %Chg | +118.90% since 12/24/25 | ||||
| Low | 8.99 on 12/26/25 | ||||
| High | 21.43 on 06/15/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 63,262,000 | ||||
| Annual Net Income | 6,815,000 | ||||
| Last Quarter Sales | 16,038,000 | ||||
| Last Quarter Net Income | 110,373,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||